Literature DB >> 1902083

Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions.

M Kusche1, H H Hannesson, U Lindahl.   

Abstract

A capsular polysaccharide from Escherichia coli K5 was previously found to have the same structure, [-(4)beta GlcA(1)----(4)alpha GlcNAc(1)-]n, as that of the non-sulphated precursor polysaccharide in heparin biosynthesis [Vann, Schmidt, Jann & Jann (1981) Eur. J. Biochem. 116, 359-364]. The K5 polysaccharide was N-deacetylated (by hydrazinolysis) and N-sulphated, and was then incubated with detergent-solubilized enzymes from a heparin-producing mouse mastocytoma, in the presence of adenosine 3'-phosphate 5'-phospho[35S] sulphate ([35S]PAPS). Structural analysis of the resulting 35S-labelled polysaccharide revealed the formation of all the major disaccharide units found in heparin. The identification of 2-O-[35S]sulphated IdoA (L-iduronic acid) as well as 6-O-[35S]sulphated GlcNSO3 units demonstrated that the modified K5 polysaccharide served as a substrate in the hexuronosyl C-5-epimerase and the major O-sulphotransferase reactions involved in the biosynthesis of heparin. The GlcA units of the native (N-acetylated) E. coli polysaccharide were attacked by the epimerase only when PAPS was present in the incubations, whereas those of the chemically N-sulphated polysaccharide were epimerized also in the absence of PAPS, in accord with the notion that N-sulphate groups are required for epimerization. With increasing concentrations of PAPS, the mono-O-sulphated disaccharide unit-IdoA(2-OSO3)-GlcNSO3- was progressively converted into the di-O-sulphated species -IdoA(2-OSO3)-GlcNSO3(6-OSO3)-. A small proportion of the 35S-labelled polysaccharide was found to bind with high affinity to the proteinase inhibitor antithrombin. This proportion increased with increasing concentration of PAPS up to a level corresponding to approximately 1-2% of the total incorporated 35S. The solubilized enzymes thus catalysed all the reactions required for the generation of functional antithrombin-binding sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902083      PMCID: PMC1150026          DOI: 10.1042/bj2750151

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  A modified uronic acid carbazole reaction.

Authors:  T BITTER; H M MUIR
Journal:  Anal Biochem       Date:  1962-10       Impact factor: 3.365

2.  Transplantable mastocytoma in the mouse containing histamine, heparin, 5-hydroxytryptamine.

Authors:  J FURTH; P HAGEN; E I HIRSCH
Journal:  Proc Soc Exp Biol Med       Date:  1957 Aug-Sep

3.  Biosynthesis of heparin. Studies on the microsomal sulfation process.

Authors:  M Höök; U Lindahl; A Hallén; G Bäckström
Journal:  J Biol Chem       Date:  1975-08-10       Impact factor: 5.157

4.  Biosynthesis of heparin. Modulation of polysaccharide chain length in a cell-free system.

Authors:  K Lidholt; J Riesenfeld; K G Jacobsson; D S Feingold; U Lindahl
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

5.  Biosynthesis of heparin. O-sulfation of the antithrombin-binding region.

Authors:  M Kusche; G Bäckström; J Riesenfeld; M Petitou; J Choay; U Lindahl
Journal:  J Biol Chem       Date:  1988-10-25       Impact factor: 5.157

6.  Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans.

Authors:  G Pejler; G Bäckström; U Lindahl; M Paulsson; M Dziadek; S Fujiwara; R Timpl
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

7.  Binding of heparin to antithrombin III: a chemical proof of the critical role played by a 3-sulfated 2-amino-2-deoxy-D-glucose residue.

Authors:  M Petitou; P Duchaussoy; I Lederman; J Choay; P Sinaÿ
Journal:  Carbohydr Res       Date:  1988-08-15       Impact factor: 2.104

8.  Extension and structural variability of the antithrombin-binding sequence in heparin.

Authors:  U Lindahl; L Thunberg; G Bäckström; J Riesenfeld; K Nordling; I Björk
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

9.  Transport of heparan sulfate into the nuclei of hepatocytes.

Authors:  M Ishihara; N S Fedarko; H E Conrad
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

10.  A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells.

Authors:  N S Fedarko; H E Conrad
Journal:  J Cell Biol       Date:  1986-02       Impact factor: 10.539

View more
  10 in total

1.  Control of the heparosan N-deacetylation leads to an improved bioengineered heparin.

Authors:  Zhenyu Wang; Bo Yang; Zhenqing Zhang; Mellisa Ly; Majde Takieddin; Shaker Mousa; Jian Liu; Jonathan S Dordick; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2011-04-12       Impact factor: 4.813

2.  Structural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII).

Authors:  A Walker; J T Gallagher
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

Review 3.  Engineering of routes to heparin and related polysaccharides.

Authors:  Ujjwal Bhaskar; Eric Sterner; Anne Marie Hickey; Akihiro Onishi; Fuming Zhang; Jonathan S Dordick; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2011-11-03       Impact factor: 4.813

4.  Occurrence of L-iduronic acid and putative D-glucuronyl C5-epimerases in prokaryotes.

Authors:  John Raedts; Servé W M Kengen; John van der Oost
Journal:  Glycoconj J       Date:  2011-02-24       Impact factor: 2.916

5.  Preparation and characterization of (15)N-enriched, size-defined heparan sulfate precursor oligosaccharides.

Authors:  Crystal Sigulinsky; Ponnusamy Babu; Xylophone V Victor; Balagurunathan Kuberan
Journal:  Carbohydr Res       Date:  2009-11-03       Impact factor: 2.104

6.  Biosynthesis of heparin. The D-glucuronosyl- and N-acetyl-D-glucosaminyltransferase reactions and their relation to polymer modification.

Authors:  K Lidholt; U Lindahl
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

7.  Synthesis of uridine 5'-diphosphoiduronic acid: a potential substrate for the chemoenzymatic synthesis of heparin.

Authors:  Michel Weïwer; Trevor Sherwood; Dixy E Green; Miao Chen; Paul L DeAngelis; Jian Liu; Robert J Linhardt
Journal:  J Org Chem       Date:  2008-08-30       Impact factor: 4.354

8.  Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry.

Authors:  Hicham Naimy; Nancy Leymarie; Michael J Bowman; Joseph Zaia
Journal:  Biochemistry       Date:  2008-02-09       Impact factor: 3.162

Review 9.  Exopolysaccharides produced by marine bacteria and their applications as glycosaminoglycan-like molecules.

Authors:  Christine Delbarre-Ladrat; Corinne Sinquin; Lou Lebellenger; Agata Zykwinska; Sylvia Colliec-Jouault
Journal:  Front Chem       Date:  2014-10-08       Impact factor: 5.221

Review 10.  Bacterial extracellular polysaccharides involved in biofilm formation.

Authors:  Barbara Vu; Miao Chen; Russell J Crawford; Elena P Ivanova
Journal:  Molecules       Date:  2009-07-13       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.